Sichuan Hz-yeg Medical Co Ltd
SICHUAN HZ-YEG MEDICAL Co Ltd operates in the pharmaceuticals industry, focusing on the development, production, and sale of medical products and services.
Business. SICHUAN HZ-YEG MEDICAL Co Ltd (300937.SZ) is a healthcare company operating in the pharmaceuticals industry, primarily engaged in pharmaceuticals and medical research. The firm generates revenue through the sale of products and is headquartered in Sichuan, China. It is listed on the Shenzhen Stock Exchange under the ticker symbol 300937.SZ. Specific details regarding operating segments or geographic revenue breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
SICHUAN HZ-YEG MEDICAL Co Ltd (300937.SZ) is a healthcare company operating in the pharmaceuticals industry, primarily engaged in pharmaceuticals and medical research. The firm generates revenue through the sale of products and is headquartered in Sichuan, China. It is listed on the Shenzhen Stock Exchange under the ticker symbol 300937.SZ. Specific details regarding operating segments or geographic revenue breakdowns are not available.
SICHUAN HZ-YEG MEDICAL Co Ltd has a debt-to-equity ratio of 0.41, indicating a relatively conservative capital structure with a moderate level of leverage. The company's liquidity is assessed as medium, and its net cash position is negative after subtracting total debt, suggesting potential short-term liquidity constraints.
In terms of profitability, the company reported a revenue of 4.45 billion CNY, but its operating cash flow is negative at -13.23 million CNY, indicating that the company is not generating sufficient cash from operations to cover its expenses. The capital expenditure of -7.57 million CNY suggests that the company is investing in its operations, but the negative cash flow from operations may limit its ability to fund these investments internally.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no detailed breakdown of geographic exposure provided in the available data. This lack of diversification may expose the company to higher risks if demand in its primary market declines.
The company's growth trajectory is not clearly defined in the available data, as there are no specific numeric deltas or revenue history provided for the current or next fiscal year. However, the company's capital expenditure suggests a commitment to maintaining or expanding its operations, which could support future growth.
The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting that the company may need to seek external financing to meet its obligations. There are no specific dilution sources or adjustments applied in the valuation data, indicating that the company has not recently issued new shares or has significant dilution potential.
Recent events and filings do not provide specific details on the company's operations or financial performance beyond the financial snapshot. The company's financial statements and disclosures do not mention any significant recent events that would impact its operations or financial position.
- SICHUAN HZ-YEG MEDICAL Co Ltd has a conservative capital structure with a debt-to-equity ratio of 0.41.
- The company's operating cash flow is negative, indicating potential liquidity constraints.
- The company's revenue is concentrated in a single business segment, with no detailed geographic exposure provided.
- The company's growth trajectory is not clearly defined, and there are no specific numeric deltas provided for the current or next fiscal year.
- The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- SICHUAN HZ-YEG MEDICAL Co Ltd Market data — financials · 2026-05-26